Director dealing

30 June 2014: Sphere Medical Holding plc (AIM: SPHR.L) (“Sphere Medical” or “the Company”), a leading developer of innovative monitoring and diagnostic products for the critical care setting, was informed on 27 June 2014 that earlier that day Dr. Wolfgang Rencken, Chief Executive Officer, purchased 11,970 ordinary shares in Sphere Medical at a price of 25p per share. Following this purchase Dr. Rencken has a beneficial interest in 11,970 ordinary shares representing 0.02% of the Company's issued ordinary share capital.